The EHR company also entered into a partnership to bring behavioral health and deidentified patient data to Holmusk’s real-world clinical database. Holmusk employs artificial intelligence to identify the most pressing behavioral health challenges and research care solutions.
“Mental and behavioral health is a serious global health problem that has only increased during and post the COVID-19 pandemic,” Veradigm CEO Rick Poulton said in a joint Jan. 9 news release. “Holmusk has proven expertise to create the evidence needed to improve mental health. We are proud to equip the company with the resources needed to advance this important work.”
Veradigm led the series B financing round, which also included Novartis venture arm dRx Capital.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
